Physician profile
Simon Raskin
NPI 1376526145
$438.46
in general payments reported to CMS, 2019-2025
6 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $159 · 2020: $158 · 2021: $121.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $290.28 | 2019-2021 | |
| Melinta Therapeutics, LLC | $61.17 | 2019 | |
| Kerecis Limited | $28.87 | 2021 | |
| Advanced Oxygen Therapy INC. | $26.04 | 2020 | |
| Merck Sharp & Dohme LLC | $16.95 | 2019 | |
| Horizon Therapeutics Plc | $15.15 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Simon Raskin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.